BOSTON SCIENTIFIC CORPORATION (BSX) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2017-03-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2017-03-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2017-03-31..
Borrowing debt
Overview →Financial period ending 2017-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2017-03-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2017-03-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2017-03-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | (m) | |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities |
| Total assets | 17.94B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | $17.94B | (m) |
| 2016-12-31 | (m) | (m) | $250.00M | (m) | (m) | (m) | $18.10B | (m) |
| 2016-09-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | $17.70B | (m) |
| 2016-06-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | $17.84B | (m) |
| 2016-03-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | $17.72B | (m) |
| 2015-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | $18.13B | (m) |
| 2015-09-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | $18.21B | (m) |
| 2015-06-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | $17.12B | (m) |
| 2015-03-31 | (m) | (m) | $400.00M | (m) | (m) | (m) | $16.47B | (m) |
| 2014-12-31 | (m) | (m) | $400.00M | (m) | (m) | (m) | $17.04B | (m) |
| 2014-09-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | $16.72B | (m) |
| 2014-06-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | $16.48B | (m) |
| 2014-03-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | $16.34B | (m) |
| 2013-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | $16.57B | (m) |
| 2013-09-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | $16.92B | (m) |
| 2013-06-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | $17.00B | (m) |
| 2013-03-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | $16.76B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |